Monday, March 02, 2015

IIR's 7th Annual Government Programs Summit

This is the Only Government Programs Event You Need to Attend

How many Government Programs events do you attend a year? IT ONLY HAS TO BE THIS ONE! IIR's 7th Annual Government Programs Summit on March 23-25, 2015 in Arlington is the one-stop-shop for all things government programs, merging regulatory compliance and financial calculations to maximize revenue potential. IIR is delivering the greatest number of government officials AND experts from pharma and biotechs — all under one roof! They'll provide policy answers to strategic, compliance, operational, technical and tactical issues on all things government programs.

IIR’s got you covered on:
  • 340B Program—HRSA, SNHPA, Pfizer, Vertex, Jansen, Hospira, Eli Lilly, Bristol-Myers Squibb
  • Medicare Part B & D—Sunovion, Daiichi, Actavis, Sanofi
  • Medicare & Medicaid—Jazz Pharmaceuticals, NCPDP, NACDS, GAO, Johnson and Johnson, BIO, GAO
  • States & State Supplemental Programs—Alabama, Oregon, Utah, Novartis
  • VA, FSS & TRICARE—VA Office of Inspector General, Daiichi, Amneal

Plus We're excited to announce that John Coster, Director, Division of Pharmacy, Center for Medicaid and CHIP Services (CMS) is confirmed to open on March 25th, 2015! Hear directly from him, as he provides insights and updates on:
  • Policy and operational issues affecting the Medicaid pharmacy program
  • Latest Medicaid DUR survey report
  • Issues and challenges facing the Medicaid pharmacy program

In addition to John Coster, hear from:
  • Health Resources and Services Administration (HRSA)—Krista M. Pedley, PharmD, MS, CDR, USPHS, Director, Office of Pharmacy Affairs
  • VA Office of Inspector General (VA)—Michael Grivnovics, Director, Federal Supply Schedule Division, Office of Contract Review
  • US Government Accountability Office (GAO)—Carolyn L. Yocom, Director, Health Care Team
  • National Association of Chain Drug Stores (NACDS)—Don Bell, Senior Vice President & General Counsel
  • National Council for Prescription Drugs (NCPDP)—Phillip Scott, SVP Business Development
  • Safety Net Hospitals for Pharmaceutical Access (SNHPA)—Jeff Davis, Counsel, Legal and Policy Affairs
  • Biotechnology Industry Organization (BIO)—Erin Estey Hertzog, Director, Reimbursement & Health Policy
NEW! Calculate liability and optimize accuracy and accountability at the newly included full-day summit on Gross-to-Net! Invite your GTN and finance peers to join and experience true collaboration by breaking down interdepartmental silos through candid conversations and networking you can only have onsite at the event.



The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment